Scynexis (SCYX) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2022)
Scynexis (SCYX) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.94% |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -77.49% |
| Dec 31, 2021 | -62.08% |
| Sep 30, 2021 | -49.39% |
| Jun 30, 2021 | -38.14% |
| Mar 31, 2021 | -28.87% |
| Dec 31, 2020 | -26.42% |
| Sep 30, 2020 | -24.71% |
| Jun 30, 2020 | -23.04% |
| Mar 31, 2020 | -21.93% |
| Dec 31, 2019 | -21.51% |
| Sep 30, 2019 | -6.28% |
| Jun 30, 2019 | 11.65% |
| Dec 31, 2018 | 12,800.00% |
| Mar 31, 2015 | -12.16% |
| Dec 31, 2014 | -10.48% |